
Margin Pressure Is Changing
Margin pressure in healthcare is still real. It just is not coming from one place. Provider EBITDA margins grew to 9.1 percent in 2024 but remain below prepandemic levels. At the same time, tariff-related expenses could materially increase hospital costs, and 94 percent of administrators expect delayed equipment upgrades due to financial strain. For multi-site healthcare organizations, that means every controllable dollar matters more.
That is why the next margin conversation needs to get more specific. In multi-site healthcare, a meaningful share of leakage sits inside the operating model itself. It hides behind fragmented purchasing, duplicate vendors, weak contract compliance, inconsistent site behavior, inventory bloat, and purchased services that expand through local habit rather than enterprise strategy. These issues rarely manifest as a single dramatic failure. They build quietly across sites until the organization starts funding variation without fully seeing it.
Purchased Services Add Up
Purchased services deserve far more executive attention than they usually get. Clinical categories tend to draw scrutiny first, but many platforms also carry unnecessary costs across waste, linen, courier, outsourced administration, telecom, facilities, and other indirect categories. Each contract may look manageable on its own. Across dozens of sites, though, small inconsistencies become material. Different renewal dates, rate cards, service levels, and vendors create cost dispersion that rarely aligns with business value. In most organizations, no one designed that complexity. It simply accumulated over time.
Inventory creates another layer of hidden drag. Multi-site operators often overprotect themselves at the site level because local teams do not trust system-wide visibility, replenishment discipline, or supplier reliability. The result is too much cash sitting on shelves, too many slow-moving items, and too many last-minute workarounds when a critical item is not where it should be. That is not just a supply chain issue. It is a working-capital issue and, in some settings, a patient access issue.
The urgency here is rising because more care continues to move into outpatient settings, payment policies continue to push lower-cost sites of care, and CMS removed 285 mostly musculoskeletal procedures from the inpatient-only list for 2026. As care spreads across more settings, complexity does not disappear. It moves outward with the footprint.

Scale Magnifies the Problem
That matters because hidden margin leaks become more expensive as organizations scale. A single site can survive local workarounds. A network of sites turns those same workarounds into systemic friction. One site buying off contract may not move the enterprise. Ten sites doing it across multiple categories will. One location carrying unnecessary inventory may not alarm Finance. A platform doing it across service lines will trap cash, raise write-offs, and create false confidence in how well the supply chain is performing.
Leadership teams that get ahead of this tend to do a few things differently. First, they build one view of spend, vendors, compliance, fill rates, and site-level behavior. Second, they separate clinical necessity from historical habit. Third, they create a lighter, clearer operating model with defined category ownership, exception management, and a regular cadence that Finance and Operations both trust. That does not require a massive central bureaucracy. It requires better visibility, clearer decision rights, and more disciplined follow-through.
The strongest scorecards also stay simple. They track the few measures that tell leadership whether value is becoming real: supply cost as a percentage of revenue, contract compliance, fill rates on critical items, days on hand, stockouts, expirations, expedited freight, and vendor performance. Those metrics do more than monitor operations. They connect sourcing and standardization decisions to EBITDA, working capital, and throughput.
Pressure Is Compounding
There is another reason this matters now. Supply shortages are adding an average of $3.5 million a year for a medium-sized health system, and 80 percent of healthcare leaders expect supply chain challenges to worsen or remain the same. On top of that, payer denials have become smaller, sneakier, and faster, with some initial denials occurring within seconds of submission. When organizations cannot control preventable cost leakage, that pressure compounds quickly.
The real takeaway is simple. Margin improvement in multi-site healthcare no longer comes only from labor management or top-line growth. It also comes from how well the organization controls fragmented spend, standardizes what should be standardized, and removes operational drift across the footprint. The leaders who treat these as enterprise issues, not site issues, are far more likely to protect margin as they grow.
About Treya Partners
Treya Partners helps multi-site healthcare organizations identify and capture value across procurement, purchased services, supply chain, and broader operating spend. Its work focuses on category strategy, sourcing execution, visibility, governance, and the practical operating disciplines that help savings show up on the P&L rather than staying trapped in analysis.